France Nuclear Imaging Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

France Nuclear Imaging Market Trends and it is segmented by Product (Equipment, Diagnostic Radioisotope), and Application (SPECT Applications, PET Applications). The report offers the value (in USD million) for the above segments.

France Nuclear Imaging Market Size

View Global Report
CAGR
Study Period 2019 - 2029
Base Year For Estimation 2023
Market Size (2024) USD 412.91 Million
Market Size (2029) USD 483.58 Million
CAGR (2024 - 2029) 3.21 %
Market Concentration Medium

Major Players

France Nuclear Imaging Market

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of France Nuclear Imaging Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

France Nuclear Imaging Market Analysis

The France Nuclear Imaging Market size is estimated at USD 412.91 million in 2024, and is expected to reach USD 483.58 million by 2029, growing at a CAGR of 3.21% during the forecast period (2024-2029).

During the COVID-19 pandemic, the nuclear imaging market in France was significantly affected as a result of lockdown and restrictions on non-essential procedures. According to a study titled 'Quantitative impact of the first COVID-19 lockdown on nuclear medicine in France: the CORALINE study' published in the National Center for Biotechnology Information in June 2021, the total number of nuclear medicine examinations performed in France dropped by 43.4% in the time span of 4 weeks before and after the lockdown. However, after the COVID-19 pandemic, the market is gaining its momentum back. Therefore, it is observed that despite the decrease in utilization of nuclear imaging during the pandemic, the market is believed to witness steady growth in the coming years.

The studied market growth can largely be attributed to factors, such as the increasing prevalence of cancer and cardiac disorders, and technological advancements in nuclear imaging. Morover, according to the United Nations Population Fund's World Population Dashboard's Statistics 2021, in France, there are about 21.1% of people aged 65 years and above. As the older population is most likely to get affected by chronic diseases, the need for devices for monitoring, diagnosis, and treatment is expected to increase over the forecast period. Thereby boosting the growth of the market studied.

Additionally, technological advancements in nuclear imaging are augmenting the growth of the market studied in France. For instance, in May 2022, physicians from Baclesse Cancer Center, France demonstrated that an artificial intelligence (AI) program can enhance image quality in half-count F-18 FDG-PET scans, opening the door to large acquisition time reductions in standard clinical practice. With the findings from various studies, nuclear medicine specialists from France have started implementing advanced technologies in PET/SPECT scans which is expected to contribute to the growth of the market studied.

France Nuclear Imaging Market Trends

This section covers the major market trends shaping the France Nuclear Imaging Market according to our research experts:

PET Radioisotopes are Expected to Witness Strong Growth in Future

The radioisotopes used in PET to label tracers are 11C, 13N, 150, and 18F (carbon, nitrogen, oxygen, and 18F are used as a substitute for hydrogen). The body will absorb these radioactive forms of natural elements, which the scanner will detect. These isotopes can be used to label a number of substances and medications.

The activities undertaken by key companies operating in the nuclear imaging market are fueling the growth of the segment. For instance, in March 2021, Eckert & Ziegler Radiopharma GmbH and Curium PET France decided to reinforce their existing long-term partnership by extending their agreement for the distribution of Galliapharm generators in France, Curium being the partner of choice given the national coverage of its PET network in France. Additionally, in August 2021, Curium submitted an Investigational New Drug (IND) application for Cu-64 PSMA I&T, a radiopharmaceutical that binds to Prostate-Specific Membrane Antigen (PSMA) for use with Positron Emission Tomography (PET), for the detection and localization of metastatic prostate cancer.

With the increasing involvement of key companies in PET radioisotope segment, it is expected that PET radioisotopes will be witnessing a healthy growth in coming years.

1

France Nuclear Imaging Industry Overview

The nuclear imaging market is highly competitive and consists of a few major players. In terms of market share, few of the major players currently dominate the market. Companies, like Bracco Imaging SpA, Curium, Cardinal Health Inc., Koninklijke Philips NV, GE Healthcare, and Siemens Healthineers, among others, hold a substantial share in the market.

France Nuclear Imaging Market Leaders

  1. GE Healthcare

  2. Canon Medical Systems

  3. Koninklijke Philips N.V.

  4. Bracco Imaging Spa

  5. Siemens AG

*Disclaimer: Major Players sorted in no particular order

Picture3.png
Need More Details on Market Players and Competitors?
Download PDF

France Nuclear Imaging Market News

  • In May 2022, Nuclear medicine physicians at the Baclesse Cancer Center in Caen, France developed an Artificial Intelligence algorithm that can be used in PET scanners to improve image quality.
  • In January 2021, Koninklijke Philips N.V. and Rennes University Hospital signed a 5-year innovation and technology partnership to support diagnostic, interventional imaging, patient monitoring, and management among other things.

France Nuclear Imaging Market Report - Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Cancer and Cardiac Disorders

      2. 4.2.2 Technological Advancements in Nuclear Imaging

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Regulations

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 Equipment

      2. 5.1.2 Diagnostic Radioisotope

        1. 5.1.2.1 SPECT Radioisotopes

        2. 5.1.2.2 PET Radioisotopes

    2. 5.2 By Application

      1. 5.2.1 SPECT Applications

        1. 5.2.1.1 Cardiology

        2. 5.2.1.2 Neurology

        3. 5.2.1.3 Thyroid

        4. 5.2.1.4 Other SPECT Applications

      2. 5.2.2 PET Applications

        1. 5.2.2.1 Oncology

        2. 5.2.2.2 Cardiology

        3. 5.2.2.3 Neurology

        4. 5.2.2.4 Other PET Applications

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Canon Medical Systems Corporation

      2. 6.1.2 Fujifilm Holdings Corporation

      3. 6.1.3 GE Healthcare

      4. 6.1.4 Koninklijke Philips NV

      5. 6.1.5 Siemens Healthineers

      6. 6.1.6 Curium

      7. 6.1.7 Mirion technologies (capintec)

      8. 6.1.8 Bracco Group

      9. 6.1.9 NOVARTIS AG (ADVANCED ACCELERATOR APPLICATIONS)

      10. 6.1.10 Bayer AG

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

France Nuclear Imaging Industry Segmentation

As per the scope of this report, nuclear medicine imaging procedures are non-invasive, with the exception of intravenous injections, and are usually painless medical tests that help physicians diagnose and evaluate medical conditions. These imaging scans use radioactive materials called radiopharmaceuticals or radiotracers. These radiopharmaceuticals are used in diagnosis and therapeutics. France Nuclear Imaging market is segmented by Product (Equipment, Diagnostic Radioisotope), and Application (SPECT Applications, PET Applications). The report offers the value (in USD million) for the above segments.

By Product
Equipment
Diagnostic Radioisotope
SPECT Radioisotopes
PET Radioisotopes
By Application
SPECT Applications
Cardiology
Neurology
Thyroid
Other SPECT Applications
PET Applications
Oncology
Cardiology
Neurology
Other PET Applications
Need A Different Region Or Segment?
Customize Now

France Nuclear Imaging Market Research FAQs

The France Nuclear Imaging Market size is expected to reach USD 412.91 million in 2024 and grow at a CAGR of 3.21% to reach USD 483.58 million by 2029.

In 2024, the France Nuclear Imaging Market size is expected to reach USD 412.91 million.

GE Healthcare, Canon Medical Systems, Koninklijke Philips N.V., Bracco Imaging Spa and Siemens AG are the major companies operating in the France Nuclear Imaging Market.

In 2023, the France Nuclear Imaging Market size was estimated at USD 400.07 million. The report covers the France Nuclear Imaging Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the France Nuclear Imaging Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.

France Nuclear Imaging Industry Report

Statistics for the 2024 France Nuclear Imaging market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. France Nuclear Imaging analysis includes a market forecast outlook 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.

close-icon
80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!

France Nuclear Imaging Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)